Vantis Investment Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-51,280
Closed -$9.58M 21
2021
Q1
$9.58M Sell
51,280
-47,800
-48% -$9.35M 9.88% 2
2020
Q4
$16.7M Sell
99,080
-55,300
-36% -$8.26M 12.45% 1
2020
Q3
$22.9M Buy
154,380
+107,700
+231% +$16.7M 10.85% 2
2020
Q2
$7.66M Buy
+46,680
New +$7.17M 6.36% 8
2017
Q3
Sell
-50,000
Closed -$4.12M 9
2017
Q2
$4.12M Hold
50,000
5.92% 8
2017
Q1
$4.21M Buy
+50,000
New +$4M 2.01% 11

Other funds holding LLY

Vantis Investment Advisers's LLY Position: Q2 2021 in Review

Vantis Investment Advisers sold out of Eli Lilly (LLY) in Q2 2021, closing a stake of 51,280 shares — an estimated $9.58M sold.

Vantis Investment Advisers first reported a position in LLY in Q1 2017 and held it in 6 quarters. The position peaked at $22.9M in Q3 2020. 2,022 funds tracked by Wall St. Rank hold LLY as of Q2 2021.

  • Vantis Investment Advisers reported no remaining Eli Lilly position as of Q2 2021 after selling out during the quarter.
  • Vantis Investment Advisers sold 51,280 Eli Lilly shares in Q2 2021, an estimated $9.58M.
  • Vantis Investment Advisers first reported a position in Eli Lilly in Q1 2017 and held it in 6 quarters.
  • Vantis Investment Advisers's Eli Lilly position peaked at $22.9M in Q3 2020.
  • 2,022 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.

Based on Vantis Investment Advisers's 13F filing for Q2 2021, filed 12 Aug 2021.